Congressional appropriations committees offered a near-total rebuke of President Trump’s proposed downsizing and reshaping of ...

Emergency room staff cut the clothes off an unresponsive homeless man, and several rats leap from his body onto the floor.

It’s a theme Eric Klein, a lawyer who co-leads Sheppard Mullin’s national health care practice, hears frequently: Hospitals ...

From STAT’s Andrew Joseph: GSK said this morning that it would buy RAPT Therapeutics in a deal worth $2.2 billion, picking up ...

This is the web edition of D.C. Diagnosis, STAT's twice-weekly newsletter about the politics and policy of health and ...

Y ou’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life ...

Kennedy Jr. appears to be reshaping another little known piece of federal vaccine infrastructure. He’s removed at least four ...

U.S. pharmaceutical companies are stepping up their campaign for higher drug prices in Europe, in some cases threatening to ...

In a surprise move, Florida officials have proposed drastically reducing eligibility for the state AIDS drug assistance ...

GSK is buying RAPT Therapeutics in a deal worth $2.2 billion, picking up an experimental medicine for food allergies.

Experts worry that health officials' use of 'shared decision-making' in new vaccine guidance distorts the concept's meaning ...

Firing the advisory panel's members could be a first step toward revamping the vaccine injury compensation system.